Optimal antithrombotic therapy in ischemic stroke patients with non-valvular atrial fibrillation and atherothrombosis: study protocol for a randomized controlled trial
Shuhei Okazaki(The University of Osaka), Hiroshi Yamagami(Osaka City University), Hirotada Maeda(National Cerebral and Cardiovascular Center), Kanta Tanaka(National Cerebral and Cardiovascular Center), Ḱazunori Toyoda(National Cerebral and Cardiovascular Center), Katsuhiro Omae(National Cerebral and Cardiovascular Center), Masafumi Ihara(National Cerebral and Cardiovascular Center), Masatoshi Koga(National Cerebral and Cardiovascular Center), Nobuyuki Sakai(Shizuoka City Shimizu Hospital), Teruo Noguchi(National Cerebral and Cardiovascular Center), Koko Asakura(National Cerebral and Cardiovascular Center), Manabu Sakaguchi(Osaka Prefectural Medical Center), Haruko Yamamoto(National Cerebral and Cardiovascular Center), Teruyuki Hirano(The Graduate University for Advanced Studies, SOKENDAI), Shiro Yamamoto(Osaka National Hospital), Yasuyuki Iguchi(Jikei University School of Medicine)
Cited by 1
Related Papers
Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
|New England Journal of Medicine|2019|823
JCS 2018 Guideline on Diagnosis and Treatment of Acute Coronary Syndrome
|Circulation Journal|2019|582